Skip to main content
Embecta Corp. logo

Embecta Corp. - Investor Relations & Filings

Listed IPO Apr 2022
Ticker · EMBC ISIN · US29082K1051 LEI · 549300RPG8GXVDHNXZ62 US Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2022-03-21 Director's Dealing
Country US United States of America
Listing US EMBC · 7 venues

Key figures FY2025

Period ended 2025-09-30 · USD
Headline annual figures for Embecta Corp., fiscal year 2025, reported in USD, with the source filing for each figure.
Total Revenues USD 1.08B per the Annual Report filed 2025-11-25
Net Income USD 95.40M per the Annual Report filed 2025-11-25
Total Assets USD 1.09B per the Annual Report filed 2025-11-25
Total Equity USD -650.60M per the Annual Report filed 2025-11-25
Cash from Ops USD 191.70M per the Annual Report filed 2025-11-25

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Embecta Corp.

https://www.embecta.com/

Embecta Corp. is a global medical device company focused on improving the health and well-being of people living with diabetes. As one of the largest pure-play diabetes care companies, it leverages a nearly 100-year legacy in insulin delivery. The company's core business involves the manufacturing and distribution of insulin delivery devices, primarily pen needles and insulin syringes, which are used by over 30 million people in more than 100 countries. Embecta is also committed to providing educational resources and support on proper injection techniques to the global diabetes community.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2022-03-21 English
10-Q
Interim / Quarterly Report Q1 2022
2022-03-16 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated March 7, 2022. It announces an investor day event and includes an investor presentation as Exhibit 99.1. The text explicitly states that the presentation materials are attached and will be available on the company's website. The document is relatively short (4234 characters) and primarily serves to furnish the investor presentation rather than being the presentation itself. According to the 'Menu vs Meal' rule, such a document that announces or furnishes a report or presentation but does not contain substantive financial data or detailed analysis itself should be classified as an Investor Presentation (IP). The presence of the investor presentation as an exhibit and the description of the event confirm this classification. Therefore, the filing type is Investor Presentation (IP) with high confidence.
2022-03-07 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a temporary suspension (blackout period) of trading under the company's employee benefits plans related to a pending spin-off. It does not contain financial statements or detailed financial data, nor is it an earnings release or annual/interim report. It is an announcement of a specific event affecting shareholders and plan participants. Given the nature of the content and the form type (8-K), this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-03-04 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated February 10, 2022. It announces the entry into a material definitive agreement related to the issuance of $500 million senior secured notes and the spin-off distribution of Embecta Corp. shares by Becton, Dickinson and Company. The document includes details about the indenture, terms of the notes, and the spin-off timeline. It also references the Form 10 Registration Statement and an Information Statement attached as Exhibit 99.1. The content focuses on financing activities, specifically the issuance of senior secured notes and related agreements, which aligns with capital and financing updates. There are no comprehensive financial statements or management discussion typical of annual or interim reports, nor is it a proxy, earnings release, or legal proceeding. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (8366 characters) supports it being a substantive filing rather than a brief announcement or certification.
2022-02-11 English
FORM 3 SUBMISSION
Director's Dealing
2022-02-11 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.